COPPOLINO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 1.768
EU - Europa 1.343
AS - Asia 283
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.398
Nazione #
US - Stati Uniti d'America 1.763
IE - Irlanda 456
SE - Svezia 434
CN - Cina 225
UA - Ucraina 133
DE - Germania 121
FI - Finlandia 64
IT - Italia 50
GB - Regno Unito 42
SG - Singapore 36
CZ - Repubblica Ceca 16
IN - India 16
BE - Belgio 11
FR - Francia 11
CA - Canada 5
IR - Iran 4
RU - Federazione Russa 4
AU - Australia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
TR - Turchia 1
Totale 3.398
Città #
Dublin 456
Chandler 439
Jacksonville 309
Nyköping 222
Beijing 112
Dearborn 87
Ashburn 70
Princeton 69
Cambridge 62
Medford 60
Des Moines 58
Ann Arbor 57
Boardman 45
New York 30
Bremen 24
Singapore 20
San Mateo 19
Lancaster 18
Brno 14
Seattle 14
Woodbridge 14
Jinan 13
Brussels 11
Nanjing 11
Shenyang 10
Wilmington 10
Leawood 8
Ningbo 8
Taizhou 8
Falls Church 7
Los Angeles 7
Pune 7
Augusta 6
Haikou 6
Hebei 6
Hefei 5
Nanchang 5
Siracusa 5
Tianjin 5
Zhengzhou 5
Foggia 4
Houston 4
Jiaxing 4
Tappahannock 4
Hangzhou 3
Hyderabad 3
Licata 3
Monmouth Junction 3
Naples 3
Norwalk 3
Ardabil 2
Caltagirone 2
Castano Primo 2
Changsha 2
Fuzhou 2
Kunming 2
London 2
Messina 2
Montreal 2
Montréal 2
Munich 2
Olomouc 2
Pescara 2
Redmond 2
Sydney 2
Taiyuan 2
Washington 2
Bilgi 1
Bologna 1
Cagliari 1
Catanzaro 1
Clearwater 1
Council Bluffs 1
Croydon 1
Cupertino 1
Eschweiler 1
Fushan 1
Guangzhou 1
Harbin 1
Helsinki 1
Jeffries 1
Lappeenranta 1
Milan 1
Mumbai 1
Nürnberg 1
Palermo 1
Puxian 1
Redwood City 1
Rome 1
Saint Paul 1
Sassari 1
Thessaloníki 1
Toronto 1
Xian 1
Yinchuan 1
Totale 2.438
Nome #
Dialysis and the Elderly: An Underestimated Problem. 76
Impaired antiviral activity of monocytes from patients on hemodiafiltration 72
The erythropoietin and regenerative medicine: a lesson from fish 71
Caffeine and the kidney: What evidence right now? 67
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 67
Cardiovascular risk impairs circulating endothelial progenitor cells mobilization during a haemodialytic session 66
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 66
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 63
Neurobiological model and quality of life in discovering personality of the uremic patient. 62
T and B lymphocytes: Chromosomic damage induced by hemodiafiltration. 62
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 62
Dialysis-related genotoxicity: Sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients - Genomic damage in patients on hemodiafiltration 61
Analysis of antiviral activity in monocytes obtained from dialysis patients 60
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 60
Cinacallcet modifies the pH of solutions in vitro: possible implications for gastro-intestinall side effects in vivo 60
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 59
Acute cardiovascular complications of hemodialysis. 59
A brief "update" on renal effects of caffeine 58
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 58
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 58
Kidney disease and psoriasis: novel evidences beyond old concepts 57
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 57
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 56
Renal complications in oncohematologic patients. 56
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 56
Therapy with vasopressin receptor antagonists: the aquaretics 56
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 55
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 55
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 55
Aquaretic agents: What's beyond the treatment of hyponatremia? 54
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 54
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 54
Effects of haemodialysis on circulating endothelial progenitor cell count 54
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 53
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 52
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 52
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 51
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 51
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 51
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 51
Erythropoietin and its lost receptor [8] 50
Pregnancy in uremic patients: An eventful journey 48
Nephro-oncology: a link in evolution 48
Management of patients after renal graft loss: an open question for nephrologists. 47
Erythropoietin and its lost receptor. 47
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 46
Pulmonary hypertension and erythropoietin. 46
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 45
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 45
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 44
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 44
Variations of macular thickness after haemodialysis. A study using optical coherence tomography (OCT) 43
Restoring the dysfunctional endothelium 42
null 39
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 39
Genomic damage in endothelial progenitor cells from uremic patients. 36
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 35
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 35
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 34
NGAL: a new missing link between inflammation and uremic anemia? 33
Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report 33
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 31
Haemodialysis: An Interesting Experimental Model 28
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 27
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 27
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 24
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 22
null 20
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 18
null 16
Totale 3.439
Categoria #
all - tutte 14.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020468 0 33 2 35 12 81 80 57 7 88 69 4
2020/2021373 57 0 70 23 15 54 3 34 7 30 59 21
2021/2022476 3 67 4 17 30 4 20 10 4 92 71 154
2022/20231.415 127 148 58 130 107 130 7 82 569 6 38 13
2023/2024278 27 49 14 28 23 73 2 19 0 7 4 32
2024/202531 26 5 0 0 0 0 0 0 0 0 0 0
Totale 3.439